Philips and Italian Fatebenefratelli Hospital Sign Multiyear Strategic Partnership to Enable Family-Centered Care for Mother and Child

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the historic San Giovanni Calibita Fatebenefratelli Hospital in Rome today announced a long-term strategic partnership to introduce state-of-the-art Family Centered Care (FCC) at the hospital. This 6-year collaboration will enable the San Giovanni Calibita to deliver developmentally focused, family centered mother-and-child care of the highest clinical quality.

The partnership, with the development of a new Neonatal Intensive Care Unit (NICU) at its core, aims at providing a safe, warm, intimate and supportive environment that accommodates ongoing family contact and reduces neonatal stress. Philips will be responsible for providing a full suite of technologies and services comprising medical equipment and accompanying maintenance, clinical informatics, innovation, training and tailored financing solutions. Philips will implement a centralized command system that works with advanced patient monitoring equipment in the NICU room to enable continuous surveillance of the neonates and monitoring of their vital signs.

The partnership between Philips and San Giovanni Calibita will strengthen the hospital’s expertise in providing mother-and-child care: today it supports the birth of 4,000 newborns and provides critical medical care for 400 premature babies each year, not only from the Lazio Region, but also from the whole of Italy.

"Dealing with the growing need for care and ever challenging budget constraints, hospitals are looking for an increased level of innovation and commitment from health technology companies like Philips," said Stefano Folli, CEO and President of Philips Italy, Israel and Greece. "We are proud to introduce a very innovative strategic collaboration model in Italy with a forward-looking institution like the San Giovanni Calibita Fatebenefratelli Hospital, thus settling a new co-creation paradigm in the healthcare industry that is leading today our business strategy."

"This is a next step forward in the renewal and revitalization of the hospital to ensure long-term excellence and innovation to citizens, always respecting our founding values," comments Dario Gaeta, Managing Director of the San Giovanni Calibita Fatebenefratelli Hospital. "Working with Philips allows us to co-create a sustainable integral solution that combines efficiency with the best possible clinical care and the sensitivity of the human touch that is needed in a NICU. This agreement is the latest in time of other partnerships the Hospital signed and is studying with other strategic partners."

The renovation and modernization work in the San Giovanni Calibita Fatebenefratelli Hospital will end in Autumn 2017. Meanwhile, the Neonatal Intensive Care Unit, which is already open to parents 24 hours a day, continues to provide high levels of care and services built around the needs of newborns and their families.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries.

About Hospital San Giovanni Calibita Fatebenefratelli
San Giovanni Calibita - Fatebenefratelli Hospital of Tiberina Island in Rome was founded in 1584. As General Hospital of the area since 1972, it is equated with public health centers, while preserving the private nature of the institution and administration owned by the Religious Hospitaller Order of Saint John of God "Fatebenefratelli". Over the years, the Hospital has experienced a constant evolution and a persistent adaptation to the needs of the territory to continue to be a reference point and a model in the area where the Fatebenefratelli religious brothers have been operating for over 500 years. Today, the Health Care Center is divided into more than twenty Departments serving all citizens from the Region and above. Several points of excellence developed over the years. Particularly, the Hospital, with about 4000 births a year, is an important reference point for maternal-fetal medicine in the area as well as the rest of Italy. Especially, women who have pathology in pregnancy (30%) are ensured access to an Intensive Care Service for Mother and Child. The Neonatal Intensive Care of the Hospital annually receives about 600 children, 400 of them are premature and subjected to periodic checks even after their discharge, for a period of 5 years, with the maximum collaboration between the various divisions of the Hospital.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...